Promoter analysis of interleukin 19

被引:9
作者
Chen, Po-Jen
Wei, Chi-Chen
Wang, Chihuei
Chen, Feng-Wei
Hsu, Yu-Hsiang
Chang, Ming-Shi [1 ]
机构
[1] Chi Mei Med Ctr, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan
[3] Chung Hwa Coll Med Technol, Dept Med Technol, Tainan, Taiwan
[4] Kaohsiung Med Univ, Orthoped Res Ctr, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ, Dept Biol, Kaohsiung, Taiwan
[6] Natl Cheng Kung Univ, Grad Inst Biochem & Mol Biol, Tainan 70101, Taiwan
[7] Natl Cheng Kung Univ, Inst Biopharmaceut Sci, Coll Med, Tainan 70101, Taiwan
关键词
interleukin-19; AMLI;
D O I
10.1016/j.bbrc.2006.03.200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin (IL)-19 belongs to the IL-10 family which includes IL-19. IL-20, IL-22, AK155, and MDA-7. IL-10 is a potent immunomodulatory cytokine with implications for pathogenesis in various autoimmune diseases. Polymorphism of' the IL-10 promoter region correlates with disease outcome. To understand the gene regulation of IL-19, we analyzed the IL-19 promoter region. A regulatory region (PE). 148 bp upstream of exon I of IL-19 and linked to a luciferase reporter gene, supported luciferase activity 13 times greater than that supported by a negative promoterless control. An electrophoretic mobility shift assay (EMSA) showed specific binding sites for the transcription factors of the oligonucleotides PE1 (-148 to -98) derived from PE. We identified the sequence TGTGGT (-142 to -138) on PEI as the binding site for the transcription factor AML1, and crucial for the promoter activity of IL-19 because Substituting 1 bp in the PE region (-139G -> T) abolished IL-19 promoter activity. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:713 / 720
页数:8
相关论文
共 17 条
[1]   Interleukin 20: Discovery, receptor identification, and role in epidermal function [J].
Blumberg, H ;
Conklin, D ;
Xu, WF ;
Grossmann, A ;
Brender, T ;
Carollo, S ;
Eagan, M ;
Foster, D ;
Haldeman, BA ;
Hammond, A ;
Haugen, H ;
Jelinek, L ;
Kelly, JD ;
Madden, K ;
Maurer, MF ;
Parrish-Novak, J ;
Prunkard, D ;
Sexson, S ;
Sprecher, C ;
Waggie, K ;
West, J ;
Whitmore, TE ;
Yao, L ;
Kuechle, MK ;
Dale, BA ;
Chandrasekher, YA .
CELL, 2001, 104 (01) :9-19
[2]   Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb [J].
BritosBray, M ;
Friedman, AD .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (09) :5127-5135
[3]   Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9 [J].
Dumoutier, L ;
Louahed, J ;
Renauld, JC .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1814-1819
[4]  
ERICKSON P, 1992, BLOOD, V80, P1825
[5]  
Frank R, 1995, ONCOGENE, V11, P2667
[6]   Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses [J].
Gallagher, G ;
Eskdale, J ;
Jordan, W ;
Peat, J ;
Campbell, J ;
Boniotto, M ;
Lennon, GP ;
Dickensheets, H ;
Donnelly, RP .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2004, 4 (05) :615-626
[7]   Cloning, expression and initial characterisation of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10) [J].
Gallagher, G ;
Dickensheets, H ;
Eskdale, J ;
Izotova, LS ;
Mirochnitchenko, OV ;
Peat, JD ;
Vazquez, N ;
Pestka, S ;
Donnelly, RP ;
Kotenko, SV .
GENES AND IMMUNITY, 2000, 1 (07) :442-450
[8]  
Jiang HP, 1995, ONCOGENE, V11, P2477
[9]   Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10 [J].
Jordan, WJ ;
Eskdale, J ;
Boniotto, M ;
Lennon, GP ;
Peat, J ;
Campbell, JDM ;
Gallagher, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) :1576-1582
[10]   CELLULAR CHARACTERISTICS OF ACUTE MYELOBLASTIC-LEUKEMIA ASSOCIATED WITH T(8-21)(Q22-Q22) [J].
KITA, K ;
SHIRAKAWA, S ;
KAMADA, N .
LEUKEMIA & LYMPHOMA, 1994, 13 (3-4) :229-234